Concord Wealth Partners Bio Techne Corp Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
A detailed history of Concord Wealth Partners transactions in Bio Techne Corp stock. As of the latest transaction made, Concord Wealth Partners holds 34 shares of TECH stock, worth $2,241. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$2,241
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TECH
# of Institutions
616Shares Held
156MCall Options Held
200KPut Options Held
15.3K-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$988 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$703 Million0.09% of portfolio
-
State Street Corp Boston, MA6.47MShares$427 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.76MShares$314 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.59B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...